Next Article in Journal
Primetime for Learning Genes
Next Article in Special Issue
Early Insights from Commercialization of Gene Therapies in Europe
Previous Article in Journal
2′-O-Methyl RNA/Ethylene-Bridged Nucleic Acid Chimera Antisense Oligonucleotides to Induce Dystrophin Exon 45 Skipping
Previous Article in Special Issue
Targeting MicroRNAs in Cancer Gene Therapy
Open AccessReview

Advances in Non-Viral DNA Vectors for Gene Therapy

1
Interdepartmental Program in Integrative Molecular and Biomedical Sciences, Baylor College of Medicine, Houston, TX 77030, USA
2
Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA
3
Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
4
Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030, USA
*
Author to whom correspondence should be addressed.
Genes 2017, 8(2), 65; https://doi.org/10.3390/genes8020065
Received: 8 November 2016 / Accepted: 1 February 2017 / Published: 10 February 2017
(This article belongs to the Special Issue Gene Therapy)
Uses of viral vectors have thus far eclipsed uses of non-viral vectors for gene therapy delivery in the clinic. Viral vectors, however, have certain issues involving genome integration, the inability to be delivered repeatedly, and possible host rejection. Fortunately, development of non-viral DNA vectors has progressed steadily, especially in plasmid vector length reduction, now allowing these tools to fill in specifically where viral or other non-viral vectors may not be the best options. In this review, we examine the improvements made to non-viral DNA gene therapy vectors, highlight opportunities for their further development, address therapeutic needs for which their use is the logical choice, and discuss their future expansion into the clinic View Full-Text
Keywords: minimized vector; antibiotic-free plasmid; miniplasmid; minicircle; minivector; DNA vaccine minimized vector; antibiotic-free plasmid; miniplasmid; minicircle; minivector; DNA vaccine
Show Figures

Figure 1

MDPI and ACS Style

Hardee, C.L.; Arévalo-Soliz, L.M.; Hornstein, B.D.; Zechiedrich, L. Advances in Non-Viral DNA Vectors for Gene Therapy. Genes 2017, 8, 65.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop